We are live on ! Find out more
RJA

Raymond James & Associates Portfolio holdings

AUM $164B
1-Year Est. Return 33.91%
This Fund
S&P 500
This Quarter Est. Return
+7.15%
1 Year Est. Return
+33.91%
3 Year Est. Return
+39.99%
5 Year Est. Return
+107.66%
10 Year Est. Return
+221.81%
AUM
$164B
AUM Growth
+$11.8B
Cap. Flow
+$2.23B
Cap. Flow %
1.36%
Top 10 Hldgs %
25.88%
Holding
4,146
New
203
Increased
1,918
Reduced
1,677
Closed
157

Sector Composition

Rank Sector Weight
1 Technology 16.27%
2 Financials 8.92%
3 Healthcare 7.98%
4 Industrials 6.57%
5 Consumer Discretionary 6.12%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GOLF icon
626
Acushnet Holdings
GOLF
$6.08B
$29.7M 0.02%
466,099
+4,300
+0.9% +$284K
CTVA icon
627
Corteva
CTVA
$60.8B
$29.7M 0.02%
505,375
+94,689
+23% +$5.17M
QYLD icon
628
Global X NASDAQ-100 Covered Call ETF
QYLD
$8.04B
$29.7M 0.02%
1,646,710
+369,343
+29% +$6.52M
APH icon
629
Amphenol
APH
$189B
$29.6M 0.02%
454,515
+108,965
+32% +$7.06M
GGG icon
630
Graco
GGG
$13.2B
$29.6M 0.02%
338,010
-16,149
-5% -$1.32M
KHC icon
631
Kraft Heinz
KHC
$32.8B
$29.5M 0.02%
841,455
-17,034
-2% -$586K
AMG icon
632
Affiliated Managers Group
AMG
$9.75B
$29.4M 0.02%
165,570
-69,077
-29% -$11.7M
GNRC icon
633
Generac Holdings
GNRC
$11.7B
$29.3M 0.02%
184,467
+6,375
+4% +$946K
SCHG icon
634
Schwab US Large-Cap Growth ETF
SCHG
$59.3B
$29.3M 0.02%
1,123,668
+28,332
+3% +$713K
UFPI icon
635
UFP Industries
UFPI
$5.01B
$29.2M 0.02%
222,660
+13,575
+6% +$1.64M
GL icon
636
Globe Life
GL
$13.9B
$29.2M 0.02%
275,479
+19,604
+8% +$1.88M
ARGX icon
637
argenx
ARGX
$55.3B
$29.2M 0.02%
53,803
-1,308
-2% -$661K
CBRE icon
638
CBRE Group
CBRE
$44.2B
$29.1M 0.02%
234,171
-2,148
-0.9% -$234K
IDXX icon
639
Idexx Laboratories
IDXX
$45B
$29M 0.02%
57,383
-22,023
-28% -$10.7M
GDDY icon
640
GoDaddy
GDDY
$14B
$28.9M 0.02%
184,618
-18,806
-9% -$2.87M
AVT icon
641
Avnet
AVT
$7.07B
$28.8M 0.02%
530,792
-32,335
-6% -$1.7M
MGK icon
642
Vanguard Mega Cap Growth ETF
MGK
$32B
$28.6M 0.02%
444,815
-29,070
-6% -$1.81M
TECH icon
643
Bio-Techne
TECH
$11.2B
$28.5M 0.02%
356,597
+8,457
+2% +$635K
LSTR icon
644
Landstar System
LSTR
$6.07B
$28.5M 0.02%
150,764
+4,345
+3% +$802K
ALC icon
645
Alcon
ALC
$34.1B
$28.4M 0.02%
283,421
-62,157
-18% -$5.85M
IJS icon
646
iShares S&P Small-Cap 600 Value ETF
IJS
$8.22B
$28.2M 0.02%
261,627
-6,269
-2% -$651K
AEM icon
647
Agnico Eagle Mines
AEM
$73.3B
$28.2M 0.02%
349,573
-5,048
-1% -$391K
MOTI icon
648
VanEck Morningstar International Moat ETF
MOTI
$74.5M
$28.2M 0.02%
803,506
-8,168
-1% -$265K
AMCR icon
649
Amcor
AMCR
$21.3B
$28.1M 0.02%
496,239
-159,679
-24% -$8.48M
WAB icon
650
Wabtec
WAB
$50.3B
$28M 0.02%
154,275
-5,394
-3% -$885K

Similar funds

Raymond James & Associates's Q3 2024 Portfolio in Review

As of Q3 2024, Raymond James & Associates held 4,146 positions worth $164B, up 7.7% from $152B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Raymond James & Associates's Q3 2024 filing shows 203 new, 1,918 increased, 1,677 reduced and 157 closed positions. Its largest new stake was AllianzIM U.S. Equity Buffer20 Aug ETF: 724,171 shares worth $20.9M. The largest sale was iShares MSCI USA Min Vol Factor ETF, an estimated $516M.

By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 17% a quarter earlier, followed by Financials and Healthcare.

  • Raymond James & Associates's largest Q3 2024 buy was AllianzIM U.S. Equity Buffer20 Aug ETF: 724,171 shares worth $20.9M.
  • Raymond James & Associates added most to iShares Core S&P Mid-Cap ETF in Q3 2024, an estimated $520M increase.
  • Raymond James & Associates's biggest Q3 2024 reduction was iShares MSCI USA Min Vol Factor ETF, cutting an estimated $516M.
  • Raymond James & Associates fully exited Ferguson in Q3 2024, selling an estimated $63.3M.
  • Raymond James & Associates's ten largest holdings make up 26% of its $164B portfolio in Q3 2024.
  • Raymond James & Associates opened 203 new positions and closed 157 in Q3 2024.
  • Raymond James & Associates's portfolio value rose 7.7% quarter-over-quarter to $164B.

Based on Raymond James & Associates's 13F filing for Q3 2024, filed 18 Oct 2024.